Zariri A - Search Results

1

An in vitro assay for toxicity testing of Clostridium perfringens type C β-toxin.

Hoonakker M, Zariri A, de Brouwer L, David D, Borgman A, Sloots A. Hoonakker M, et al. Among authors: zariri a. Front Immunol. 2024 Apr 5;15:1373411. doi: 10.3389/fimmu.2024.1373411. eCollection 2024. Front Immunol. 2024. PMID: 38646535 Free PMC article.

2

Lipid A heterogeneity and its role in the host interactions with pathogenic and commensal bacteria.

Saha S, Pupo E, Zariri A, van der Ley P. Saha S, et al. Among authors: zariri a. Microlife. 2022 Jun 10;3:uqac011. doi: 10.1093/femsml/uqac011. eCollection 2022. Microlife. 2022. PMID: 37223360 Free PMC article. Review.

3

An Intranasal OMV-Based Vaccine Induces High Mucosal and Systemic Protecting Immunity Against a SARS-CoV-2 Infection.

van der Ley PA, Zariri A, van Riet E, Oosterhoff D, Kruiswijk CP. van der Ley PA, et al. Among authors: zariri a. Front Immunol. 2021 Dec 17;12:781280. doi: 10.3389/fimmu.2021.781280. eCollection 2021. Front Immunol. 2021. PMID: 34987509 Free PMC article.

4

Shortening the Lipid A Acyl Chains of Bordetella pertussis Enables Depletion of Lipopolysaccharide Endotoxic Activity.

Arenas J, Pupo E, Phielix C, David D, Zariri A, Zamyatina A, Tommassen J, van der Ley P. Arenas J, et al. Among authors: zariri a. Vaccines (Basel). 2020 Oct 9;8(4):594. doi: 10.3390/vaccines8040594. Vaccines (Basel). 2020. PMID: 33050234 Free PMC article.

5

Modulating endotoxin activity by combinatorial bioengineering of meningococcal lipopolysaccharide.

Zariri A, Pupo E, van Riet E, van Putten JP, van der Ley P. Zariri A, et al. Sci Rep. 2016 Nov 14;6:36575. doi: 10.1038/srep36575. Sci Rep. 2016. PMID: 27841285 Free PMC article.

6

Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response.

Zariri A, Beskers J, van de Waterbeemd B, Hamstra HJ, Bindels TH, van Riet E, van Putten JP, van der Ley P. Zariri A, et al. Infect Immun. 2016 Sep 19;84(10):3024-33. doi: 10.1128/IAI.00635-16. Print 2016 Oct. Infect Immun. 2016. PMID: 27481244 Free PMC article.

7

Biosynthetically engineered lipopolysaccharide as vaccine adjuvant.

Zariri A, van der Ley P. Zariri A, et al. Expert Rev Vaccines. 2015 Jun;14(6):861-76. doi: 10.1586/14760584.2015.1026808. Epub 2015 Mar 22. Expert Rev Vaccines. 2015. PMID: 25797360 Free article. Review.

8

Meningitis caused by a lipopolysaccharide deficient Neisseria meningitidis.

Piet JR, Zariri A, Fransen F, Schipper K, van der Ley P, van de Beek D, van der Ende A. Piet JR, et al. Among authors: zariri a. J Infect. 2014 Oct;69(4):352-7. doi: 10.1016/j.jinf.2014.06.005. Epub 2014 Jun 13. J Infect. 2014. PMID: 24932738

9

Expression of human CEACAM1 in transgenic mice limits the Opa-specific immune response against meningococcal outer membrane vesicles.

Zariri A, van Dijken H, Hamstra HJ, van der Flier M, Vidarsson G, van Putten JP, Boog CJ, van den Dobbelsteen G, van der Ley P. Zariri A, et al. Vaccine. 2013 Nov 12;31(47):5585-93. doi: 10.1016/j.vaccine.2013.07.069. Epub 2013 Aug 6. Vaccine. 2013. PMID: 23933369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters